Red blood cell polyagglutination: Clinical aspects

Seminars in Hematology

Volumn 37, Issue 2, 2000, Pages 186-196

  Beck, Malcolm L ^a  

^a Division of New York Blood Center Enterprises   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; DISEASE ASSOCIATION; HEMAGGLUTINATION; HEMOLYSIS; HEMOLYTIC UREMIC SYNDROME; PRIORITY JOURNAL; SOMATIC MUTATION;

EID: 0034074866     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(00)90043-X     Document Type: Article

References (92)

1. Andreu G, Doinel C, Cartron J-P, et al: Induction of Tk polyagglutination by Bacteroides fragilis culture supernatants. Associated modifications of A B H and I i antigens. Rev Fr Transfus Immunohematol 22:551-561, 1979
2. Baldwin ML, Barrasso C, Ridolfi RL: Tn-polyagglutinability associated with acute myelomonocytic leukemia. Am J Clin Pathol 72:1024-1027, 1979
3. Beck ML: The technical problem of T-activation. Transfusion 8:109-110, 1968
4. Beck ML: Erroneous blood typing due to polyagglutination. Med Lab Technol 29:55-58, 1972
5. Beck ML: Tn: A nonmicrobial form of polyagglutination, in Beck ML, Judd WJ (eds): Polyagglutination: A Technical Workshop. Washington, DC, American Association of Blood Banks, 1980, pp 55-70
6. Beck ML: Blood group antigens acquired de novo, in Garratty G (ed): Blood Group Antigens and Disease. Arlington, VA, American Association of Blood Banks, 1983, pp 45-65
7. Beck ML, Hicklin B, Pierce SR: Unexpected limitations in the use of commercial antiglobulin reagents. Transfusion 16:71-75, 1976
8. Beck ML, Hicklin BL, Pierce SR, et al: Observations on leucocytes and platelets in six cases of Tn-polyagglutination. Med Lab Sci 34:325-329, 1977
9. Beck ML, Kowalski MA, Kirkegaard JR, et al: Report on section 2A antibodies: ABH and other glycoconjugates - Serology. Transfus Clin Biol 4:29-34, 1997
10. Beck ML, Marsh WL: Red cell Sp1 antigen change associated with in vivo polyagglutinability. Vox Sang 19:91-93, 1970
11. Beck ML, Myers MA, Moulds MJ, et al: Coexistent Tk and VA polyagglutinability. Transfusion 18:680-684, 1978
12. Beck ML, Walker RH, Oberman HA: Atypical polyagglutination associated with an acquired B antigen. Transfusion 11:296-301, 1971
13. Bird AR, Kent P, Moores PP, et al: Haemoglobin M-Hyde Park associated with polyagglutinable red blood cells in a South African family. Br J Haematol 68:459-464, 1988
14. Bird GWG: Anti-T in peanuts. Vox Sang 9:748-749, 1964
15. Bird GWG: Lectins and red cell polyagglutinability: History, comments and recent developments, in Beck ML, Judd WJ (eds): Polyagglutination: A Technical Workshop. Washington, DC, American Association of Blood Banks, 1980, pp 71-90
16. Bird GWG: Clinical aspects of red blood cell polyagglutinability of microbial origin, in Salmon C (ed): Blood Groups and Other Red Cell Surface Markers in Health and Disease. New York, NY, Masson, 1982, pp 55-64
17. Bird GWG, Wingham J: Tk: a new form of red cell polyagglutination. Br J Haematol 23:759-763, 1972
18. Bird GWG, Wingham J: Seed agglutinin for rapid identification of Tn-polyagglutination. Lancet 1:677, 1973
19. Bird GWG, Wingham J, Beck ML, et al: Th, a "new" form of erythrocyte polyagglutination. Lancet 1:1215-1216, 1978
20. Bird GWG, Wingham J, Pippard MJ, et al: Erythrocyte membrane modification in malignant diseases of myeloid and lymphoreticular tissues. I. Tn-polyagglutination in acute myelocytic leukaemia. Br J Haematol 33:289-294, 1976
21. Bird GWG, Wingham J, Richardson SG: Myelofibrosis, autoimmune haemolytic anaemia and Tn-polyagglutinability. Haematologia 18:99-103, 1985
22. Bird GWG, Wingham J, Seger R, et al: Tx, a "new" red cell cryptantigen exposed by pneumococcal enzymes. Rev Fr Transfus Immunohematol 25:215-216, 1982
23. Bird T, Stephenson J: Acute haemolytic anaemia associated with polyagglutinability of red cells. J Clin Pathol 26:868-870, 1973
24. Blumenfeld OO, Lalezari P, Khorshidi M, et al: O-linked oligosaccharides of glycophorins A and B in erythrocytes of two individuals with the Tn polyagglutinability syndrome. Blood 80:2388-2395, 1992
25. Cartron J-P, Andreu G, Cartron J, et al: Demonstration of T-transferase deficiency in Tn-polyagglutinable blood samples. Eur J Biochem 92:111-119, 1978
26. Cartron J-P, Blanchard D: Association of human erythrocyte membrane glycoproteins with blood-group Cad specificity. Biochem J 207:497-504, 1982
27. Cartron J-P, Blanchard D, Nurden A, et al: Tn syndrome: A disorder affecting red blood cell, platelet, and granulocyte cell surface components, in Salmon C (ed): Blood Groups and Other Red Cell Markers in Health and Disease. New York, NY, Masson, 1983, pp 39-54
28. Cazal P, Monis M, Caubel J, et al: Hereditary dominant polyagglutinability: Private antigen (Cad) corresponding to a public antibody and a lectin of Dolichos biflorus. Rev Fr Transfus 11:209-221, 1968
29. Coon JS, Weinstein RS, Summers JL: Blood group precursor T-antigen expression in human urinary bladder carcinoma. Am J Clin Pathol 77:692-699, 1982
30. Crookston JH, Crookston MC, Burnie KL, et al: Hereditary erythroblastic multinuclearity associated with a positive acidified-serum test: A type of congenital dyserythropoietic anaemia. Br J Haematol 17:11-26, 1969
31. Crookston JH, Crookston MC, Rosse WF: Red-cell abnormalities in HEMPAS (hereditary erythroblastic multinuclearity with a positive acidified-serum test). Br J Haematol 23:83-91, 1972 (suppl)
32. Dahr W, Uhlenbruck G, Gunson HH, et al: Molecular basis of Tn-polyagglutinability. Vox Sang 29:36-50, 1975
33. Dausset J, Moullec J, Bernard J: Acquired hemolytic anemia with polyagglutinability of red blood cells due to a new factor present in normal human serum (anti-Tn). Blood 14:1079-1093, 1959
34. Doinel C, Andreu G, Cartron J-P, et al: Tk polyagglutination produced in vitro by an endo-beta-galactosidase. Vox Sang 38:94-98, 1980
35. Doinel C, Rufin JM, Andreu G: The Tk antigenic determinant: Studies of Tk-activated red blood cells with endoglycosidases. Rev Fr Transfus Immunohematol 24:109-116, 1981
36. Fischer K, Poschmann A, Oster H: Severe pneumonia with hemolysis caused by neuraminidase. Detection of cryptantigens by indirect immunofluorescent technic. Monatsschr Kinderheilkd 119:2-8, 1971
37. Fukuda MN: HEMPAS disease: Genetic defect of glycosylation. Glycobiology 1:9-15, 1990
38. Fukuda MN, Masri KA, Dell A, et al: Incomplete synthesis of N-glycans in congenital dyserythropoietic anemia type II caused by a defect in the gene encoding α-mannosidase II. Proc Natl Acad Sci USA 87:7443-7447, 1990
39. Garratty G, Willbanks E, Petz LD: An acquired B antigen associated with Proteus vulgaris infection. Vox Sang 21:45-56, 1971
40. Graninger W, Poschmann A, Fischer K, et al: 'VA,' a new type of erythrocyte polyagglutination characterized by depressed H receptors and associated with hemolytic anemia. II. Observations by immunofluorescence, electron microscopy, cell electrophoresis and Biochemistry. Vox Sang 32:201-207, 1977
41. Graninger W, Rameis H, Fischer K, et al: "VA," a new type of erythrocyte polyagglutination characterized by depressed H receptors and associated with hemolytic anemia. I. Serological and hematological observations. Vox Sang 32:195-200, 1977
42. Hamilton DV, Black AJ, Darnborough J, et al: Haemolyticuraemic syndrome and T-activation of red blood cells. Clin Lab Haematol 5:109-112, 1983
43. Harris PA, Roman GK, Moulds JJ, et al: An inherited RBC characteristic, NOR, resulting in erythrocyte polyagglutination. Vox Sang 42:134-140, 1982
44. Heddle NM, Blajchman MA, Bodner N, et al: Absence of hemolysis of T-activated red cells following infusion of blood products. Transfusion 17:686, 1987 (abstr)
45. Herkt F, Parente JP, Leroy Y, et al: Structure determination of oligosaccharides isolated from Cad erythrocyte membranes by permethylation analysis and 500-MHz 1H- NMR spectroscopy. Eur J Biochem 146:125-129, 1985
46. Herman JH, Shirey RS, Smith B, et al: Th activation in congenital hypoplastic anermia. Transfusion 27:253-256, 1987
47. Inglis G, Bird GW, Mitchell AA, et al: Effect of Bacteroides fragilis on the human erythrocyte membrane: pathogenesis of Tk polyagglutination. J Clin Pathol 28:964-968, 1975
48. Inglis G, Bird GWG, Mitchell AA, et al: Tk polyagglutination associated with reduced A and H activity. Vox Sang 35:370-374, 1978
49. Issitt PD, Anstee DJ: Applied Blood Group Serology (ed 4). Durham, NC, Montgomery Scientific, 1998
50. Janvier D, Guignier F, Reviron M, et al: Concomitant exposure of Tn and Th cryptantigens on the red cells of a patient with myelodysplasia. Vox Sang 61:142-143, 1991
51. Janvier D, Reviron M, Reviron J: Two types of polyagglutinability are associated with the acquired B transformation. Transfusion 21:412, 1983 (abstr)
52. Jiji RM: Case report referred to in July 1979 issue of Blood article by Ness et al: "Tn polyagglutination preceding acute leukemia," Blood 54:1451, 1979 (letter)
53. Jorgensen JR: Prenatal T-transformation? A case of polyagglutinable cord blood erythrocytes. Vox Sang 13:225-232, 1967
54. Judd WJ: The role of exo-β-galactosidase in Tk-activation. Transfusion 20:622, 1980 (abstr)
55. Judd WJ: The role of lectins in blood group serology. Crit Rev Clin Lab Sci 12:171-214, 1980
56. Judd WJ, Beck ML, Hicklin BL, et al: BS II lectin: A second hemagglutinin isolated from Bandeiraea. simplicifolia seeds with affinity for type III polyagglutinable red cells. Vox Sang 33:246-251, 1977
57. Judd WJ, McGuire-Mallory D, Anderson KM, et al: Concomitant T- and Tk-activation associated with acquired-B antigens. Transfusion 19:293-298, 1979
58. King MJ, Liew YW, Moores PP, et al: Enhanced reaction with Vicia graminea, lectin and exposed terminal N-acetyl-D-glucosaminyl residues on a sample of human red cells with Hb M-Hyde Park. Transfusion 28:549-555, 1988
59. Klein PJ, Bulla M, Newman RA, et al: Thomsen-Friedenreich antigen in haemolytic-uraemic syndrome. Lancet 2:1024-1025, 1977
60. Laurent JC, Noel P, Faucon M: Expression of a cryptic cell surface antigen in primary cell cultures from human breast cancer. Biomedicine 29:260-261, 1978
61. Levene C, Sela R, Blat J, et al: Intravascular [correction of intracellular] hemolysis and renal failure in a patient with T polyagglutination. Transfusion 26:243-245, 1986 (erratum, 26:422, 1986)
62. Levene NA, Levene C, Gekker K, et al: Th polyagglutination with fatal outcome in a patient with massive intravascular hemolysis and perforated tumor of colon. Am J Hematol 35:127-128, 1990
63. Levine P, Katzin EM: Temporary agglutination of red blood cells. Proc Soc Exp Biol Med 39:167-169, 1938
64. Liew YW, Bird GWG, King MJ: The human erythrocyte cryptantigen Tk: Exposure by an endo-beta-galactosidase from Flavobacterium kemtolycus. Rev Fr Transius Immunohematol 25:639-641, 1982
65. Marsh WL: The pseudo B antigen: A study of its development. Vox Sang 5:387-397, 1960
66. Mollison PL, Engelfriet CP, Contreras M: Blood Transfusion in Clinical Medicine (ed 10). Oxford, England, Blackwell Science, 1997
67. Mullard GW, Haworth C, Lee D: A case of atypical polyagglutinability due to Tk-transformation. Br J Haematol 40:571-582, 1978
68. Mullard GW, Thompson IH, Lee D, et al: Strong T-transformation associated with a severe haemolytic reaction in a young infant transfused with packed red cells. Clin Lab Haematol 3:357-364, 1981
69. Myllyla G, Furuhjelm U, Nordling S, et al: Persistent mixed field polyagglutinability. Electrokinetic and serological aspects. Vox Sang 20:7-23, 1971
70. Ness PM, Garratty G, Morel PA, et al: Tn polyagglutination preceding acute leukemia. Blood 54:30-34, 1979
71. Obeid D, Bird GWG, Wingham J: Prolonged erythrocyte T-polyagglutination in two children with bowel disorders. J Clin Pathol 30:953-955, 1977
72. Poschmann A, Fischer K: Hemolytic-uremic syndrome. Review and new pathogenetic aspects. Med Klin 69:1821-1834, 1974
73. Race RR, Sanger R: Blood Groups in Man (ed 6), Oxford, England, Blackwell Scientific, 1975
74. Reid ME, Halverson GR, Lee AH, et al: Tr: A new type of polyagglutination. Transfusion 38:100S, 1998 (suppl, abstr)
75. Roxby DJ, Pfeiffer MB, Morley AA, et al: Expression of the Tn antigen in myelodysplasia, lymphoma, and leukemia. Transfusion 32:834-838, 1992
76. Sanger R, Gavin J, Tippett P, et al: Plant agglutinin for another human blood-group. Lancet 1:1130-1130, 1971
77. Seger R, Joller P, Bird GWG, et al: Necrotising enterocolitis and neuraminidase-producing bacteria. Helv Paediatr Acta 35:121-128, 1980
78. Seger R, Joller P, Kenny A, et al: Potential hazards of blood-transfusion in Clostridia-associated necrotising enterocolitis. Lancet 1:48-49, 1979
79. Seger RA, Kenny A, Bird GWG, et al: Pediatric surgical patients with severe anaerobic infection: Report of 16 T-antigen positive cases and possible hazards of blood transfusion. J Pediatr Surg 16:905-910, 1981
80. Sondag-Thull D, Levene NA, Levene C, et al: Characterization of a neuraminidase from Corynebacterium aquaticum responsible for Th polyagglutination. Vox Sang 57:193-198, 1989
81. Springer GF: T and Tn, general carcinoma autoantigens. Science 224:1198-1206, 1984
82. Springer GF, Desai PR: Detection of lung- and breast carcinoma by quantitating serum anti-T IgM levels with a sensitive, solid-phase immunoassay. Naturwissenschaften 69: 346-348, 1982
83. Springer GF, Desai PR, Fry WA, et al: Importance of breast-, lung-, and pancreas carcinoma cell membrane T antigen in their immunodiagnosis, in Galeott T (ed): Membranes in Tumour Growth. Amsterdam, the Netherlands, Elsevier Biomedical, 1982, pp 575-582
84. Springer GF, Murthy MS, Desai PR, et al: Breast cancer patient's cell-mediated immune response to Thomsen-Friedenreich (T) antigen. Cancer 45:2949-2954, 1980
85. Springer GF, Murthy SM, Desai PR: Diagnosis of breast carcinoma with Thomsen-Friedenreich (T) antigen and antibody. Breast 7:24-30, 1981
86. Springer GF, Taylor CR, Howard DR, et al: Tn, a carcinoma-associated antigen, reacts with anti-Tn of normal human sera. Cancer 55:561-569, 1985
87. Thatcher N, Hashmi K, Chang J, et al: Anti-T antibody in malignant melanoma patients. Influence of response and survival following chemotherapy - Changes in serum levels following Cparvum, BCG immunization. Cancer 46:1378-1382, 1980
88. Thomas DB, Winzler RJ: Structural studies on human erythrocyte glycoproteins. Alkalilabile oligosaccharides. J Biol Chem 244:5943-5946, 1969
89. Vaith P, Uhlenbruck G: The Thomsen agglutination phenomenon: A discovery revisited 50 years later. Z Immunitatsforsch Immunobiol 154:1-15, 1978
90. van Loghem JJ, van der Hart M, Land ME: Polyagglutinability of red cells as a cause of severe haemolytic transfusion reaction. Vox Sang 5:125-129, 1955
91. Wahl CM, Herman JH, Shirey RS, et al: Th activation of maternal and cord blood. Transfusion 29:635-637, 1989
92. Wolach B, Sadan N, Bird GWG, et al: Tx polyagglutination in three members of one family. Acta Haematol 78:45-47, 1987